Differentiating the Treatment of Asthma and Chronic Obstructive Pulmonary Disease in the Elderly Patient
Keywords: Asthma; COPD = Chronic obstructive pulmonary disease; Chronic obstructive pulmonary disease; DPI = Dry-powder inhaler; ED = Emergency department; Elderly; FDA = Food and Drug Administration; FEV1 = Forced expiratory volume in 1 second; FVC = Forced vital capacity; GERD = Gastroesophageal reflux disease; GINA = Global Initiative for Asthma; GOLD = Global Initiative for Chronic Obstructive Lung Disease; Geriatric; HFA = Hydrofluoroalkane; ICS = Inhaled corticosteroid; INR = International normalized ratio; LABA = Long acting β2 agonist; MDI = Metered-dose inhaler; NAEPP = National Asthma Education and Prevention Program; NHLBI = National Heart, Lung, and Blood Institute; PEF = Peak expiratory flow; Pharmacotherapy; SABA = Short-acting β2 agonist; Treatment guidelines
Document Type: Research Article
Publication date: 01 September 2012
- The Consultant Pharmacist® is the official peer-reviewed journal of the American Society of Consultant Pharmacists. It is dedicated exclusively to the medication needs of the elderly in all settings, including adult day care, ambulatory care, assisted living, community, hospice, and nursing facilities. This award-winning journal is a member benefit of ASCP. Individuals who are not members and wish to receive The Consultant Pharmacist® will want to consider joining ASCP.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- ">
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content